Artificial intelligence and aneuploidy prenatal screening
10.3760/cma.j.cn113903-20210325-00258
- VernacularTitle:人工智能与非整倍体产前筛查
- Author:
Falin HE
1
;
Zhiguo WANG
;
Juntao LIU
Author Information
1. 北京医院国家老年医学中心，国家卫生健康委临床检验中心，北京市临床检验工程技术研究中心，中国医学科学院老年医学研究院 100730
- Keywords:
Artificial intelligence;
Aneuploidy;
Prenatal diagnosis
- From:
Chinese Journal of Perinatal Medicine
2021;24(11):868-871
- CountryChina
- Language:Chinese
-
Abstract:
This article reviews the emerging artificial intelligence (AI) technology and its application in the field of aneuploidy prenatal screening from the aspects of the research methods of AI, the status of prenatal screening, and the role of AI in the integration of the screening markers, improvement of the screening performance, and optimization of screening strategy, etc. There is no doubt that AI has great potential in improving the ability of disease prediction through, integrating various screening data, discovering additional value of the data, and reducing social medical expenses. However, AI technology should be viewed and used in a scientific, rational, and comprehensive way to achieve the ideal effect in the field of prenatal screening.
